Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024)
Whitehawk Therapeutics (WHWK) reported Current Leases of $268000.0 for Q4 2024, down 38.25% year-over-year from $434000.0 in Q1 2024, and down 16.77% quarter-over-quarter from $322000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 6 years of Current Leases data on file, last reported at $268000.0 in Q4 2024.
- Current Leases for Q4 2024 came in at $268000.0, down 38.25% year-over-year; the trailing twelve-month figure through Dec 2024 was $268000.0 (down 38.25% YoY), and the FY2024 annual result was $268000.0, down 38.25% from the prior year.
- Current Leases eased to $268000.0 in Q4 2024 per WHWK's latest filing, from $322000.0 in the prior quarter.
- Over five years, Current Leases peaked at $434000.0 in Q4 2023 and troughed at $9955.0 in Q2 2021.
- A 5-year average of $251285.0 and a median of $295000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2022: Current Leases slumped 91.04% in 2021, then soared 3154.65% in 2022.
- A 5-year view of Current Leases shows it stood at $125000.0 in 2020, then advanced by 4.8% to $131000.0 in 2021, then surged by 200.76% to $394000.0 in 2022, then advanced by 10.15% to $434000.0 in 2023, then plunged by 38.25% to $268000.0 in 2024.
- Business Quant data shows WHWK's Current Leases at $268000.0 in Q4 2024, $322000.0 in Q3 2024, and $374000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 374,000.00 |
| Mar 31, 2024 | 425,000.00 |
| Dec 31, 2023 | 434,000.00 |
| Sep 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 413,000.00 |
| Mar 31, 2023 | 404,000.00 |
| Dec 31, 2022 | 394,000.00 |
| Sep 30, 2022 | 374,000.00 |
| Jun 30, 2022 | 324,000.00 |
| Mar 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 9,955.00 |
| Mar 31, 2021 | 39,171.00 |
| Dec 31, 2020 | 125,000.00 |
| Sep 30, 2020 | 94,787.00 |
| Jun 30, 2020 | 111,053.00 |
| Mar 31, 2020 | 106,734.00 |